Pending research issues in male condom use promotion
Richard Crosby A B D and Lee Warner CA College of Public Health, University of Kentucky, 121 Washington Avenue, Lexington, KY 40506, USA.
B Rural Center for AIDS/STD Prevention, Indiana University, 801 East 7th Street, Bloomington, IN 47405, USA.
C Centers for Disease Control and Prevention, Division of Reproductive Health, Atlanta, GA 30341, USA.
D Corresponding author. Email: crosby@uky.edu
Sexual Health 5(4) 317-319 https://doi.org/10.1071/SH08080
Submitted: 28 October 2008 Accepted: 30 October 2008 Published: 18 November 2008
Abstract
Sufficient evidence has accumulated to warrant the expansion of condom use research in several additional directions. Possible risk compensation pertaining to human papillomavirus vaccination and vaginal microbicides is one example. A second area of needed research involves the question of when couples can be advised to safely discontinue condom use given that ‘lifelong’ condom use is not a realistic goal for most people. A third example is intensified research designed to identify more effective means of mass marketing condoms and their use as a health-protective behaviour. As the AIDS and sexually transmissible infection pandemics persist, intensified condom promotion research is an ethical imperative.
Additional keywords: condom effectiveness, condom failure, sexual behaviour, sexually transmissible infections.
[1]
[2] Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82 454–61.
| PubMed |
[3] Warner L, Stone KM, Macaluso M, Buehler J, Austin HD. Condom use and risk of gonorrhea and chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis 2006; 33 36–51.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[4] Weller S, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2001;: CD003255.
| CAS | PubMed |
[5] Warner L, Macaluso M, Austin HD, Kleinbaum DK, Artz L, Fleenor ME, et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161 765–73.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[6] Warner L, Newman DR, Austin HD, Kamb ML, Douglas JM, Malotte CK, et al. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol 2004; 159 242–51.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[7] Winer RL, Hughes JP, Feng Q, O’Reilly S, Kiviat NB, Holmes KK, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354 2645–54.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
[8] Hogewoning CJA, Bleeker MCG, van den Brule AJC, Voorhorst FJ, Snijders PJF, Berkhof J, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized controlled trial. Int J Cancer 2003; 107 811–16.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
[9] Crosby RA, Salazar LF, DiClemente RJ, Yarber WL, Caliendo AM, Staples-Horne M. Accounting for failures may improve precision: evidence supporting improved validity of self-reported condom use. Sex Transm Dis 2005; 32 513–15.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[10] Crosby RA, Sanders S, Yarber WL, Graham C, Dodge B. Condom use errors and problems among college men. Sex Transm Dis 2002; 29 552–7.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[11] Crosby RA, Sanders SA, Yarber WL, Graham CA. Condom use errors and problems: a neglected aspect of studies assessing condom effectiveness. Am J Prev Med 2003; 24 367–70.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[12] Civic D, Scholes D, Ichikawa L, Grothaus L, McBride CM, Yarnall KSH. Ineffective use of condoms among young women in managed care. AIDS Care 2002; 14 779–88.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
[13] Macaluso M, Kelaghan J, Artz L, Austin H, Fleenor M, Hook EW, et al. Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis 1999; 26 450–7.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
[14] Warner L, Clay-Warner J, Boles J, Williamson J. Assessing condom use practices: implications for evaluating method and user effectiveness. Sex Transm Dis 1998; 6 273–7.
[15] Shlay JC, McClung MW, Patnaik JL, Douglas JM. Comparison of sexually transmitted disease prevalence by reported condom use: errors among consistent condom users seen at an urban sexually transmitted disease clinic. Sex Transm Dis 2004; 31 526–32.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[16] Macaluso M, Blackwell R, Jamieson DJ, Kulczycki A, Chen MP, Akers R, et al. Efficacy of the male latex condom and of the female polyurethane condom as barriers to semen during intercourse: a randomized clinical trial. Am J Epidemiol 2007; 166 88–96.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[17] Koutsky L, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347 1645–51.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
[18] Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsagué X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348 518–27.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[19] van de Wijgert J, Coggins C. Microbicides to prevent heterosexual transmission of HIV: ten years down the road. AIDScience 2002; 15 23–8.
[20] Mantell JE, Myer L, Carballo-Dieguez A, Steina Z, Ramjee G, Morar NS, et al. Microbicide acceptability research: current approaches and future directions. Soc Sci Med 2005; 60 319–30.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[21] Ramjee G, Shattock R, Delany S, McGowan I, Morar N, Gottemoeller M. Microbicides 2006 conference. AIDS Res Ther 2006; 3 25.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[22] Kajubi P, Kamya MR, Kamya S, Chen S, McFarland W, Hearst N. Increasing condom use without reducing HIV risk: results of a controlled community trial in Uganda. J Acquir Immune Defic Syndr 2005; 40 77–82.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[23] Smoak ND, Scott-Sheldon LA, Johnson BT, Carey MP. Sexual risk reduction interventions do not inadvertently increase the overall frequency of sexual behavior: a meta-analysis of 174 studies with 116,735 participants. J Acquir Immune Defic Syndr 2006; 41 374–84.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[24] Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51 1–60.
[25] Crosby RA, DiClemente RJ, Holtgrave DR, Wingood GM. Design, measurement, and analytic considerations for testing hypotheses relative to condom effectiveness against non-viral STIs. Sex Transm Infect 2002; 78 228–31.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
[26] Crosby RA, Graham CA, Yarber WL, Sanders SA. If the condom fits, wear it: a qualitative study of young African American men. Sex Transm Infect 2004; 80 306–9.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
[27] Crosby RA, Yarber WL, Sanders SA, Graham CA. Condom discomfort and associated problems with their use among university students. J Am College Health 2005; 54 143–8.
| Crossref | GoogleScholarGoogle Scholar |
[28] Crosby RA, Yarber WL, Sanders SA, Graham CA, McBride K, Milhausen RR, et al. Men with broken condoms: who and why? Sex Transm Infect 2007; 83 71–5.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
[29] Cook L, Nanda K, Taylor D. Randomized crossover trial comparing the eZ.on plastic condom and a latex condom. Contraception 2001; 63 25–31.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |
[30] Trussell J, Warner DL, Hatcher RA. Condom breakage and slippage rates. Fam Plann Perspect 1992; 24 20–3.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |